Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$8.43 - $20.9 $143,975 - $356,951
-17,079 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$19.26 - $30.08 $76,462 - $119,417
3,970 Added 30.28%
17,079 $349,000
Q3 2021

Nov 12, 2021

BUY
$24.86 - $35.02 $325,889 - $459,077
13,109 New
13,109 $335,000
Q4 2017

Feb 14, 2018

SELL
$2.59 - $5.44 $72,030 - $151,291
-27,811 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$3.2 - $5.57 $88,995 - $154,907
27,811
27,811 $146,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $398M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.